Pacira BioSciences, Inc. PCRX

US Pharmaceuticals

$36.46 ▲ +0.00% (+$0.00)

Open $36.47

Prev Close $36.46

Day Range $36.45 – $36.48

52W Range $18.80 – $36.67

Market Cap $1.45B

P/E (TTM) 99.87

Beta 0.16

EPS (TTM) $0.35

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2011-02-03
Shares Out.	39,910,000
Website	pacira.com/ ↗
Phone	13026587581
Employees	829
Revenue	$192.4M
Gross Profit	$148.2M
Net Income	$4.7M
Free Cash Flow	$179.5M
Total Assets	$1.24B
Total Liabilities	$572.0M
Equity	$672.0M

About Pacira BioSciences, Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Pacira BioSciences, Inc. is a publicly traded company under the ticker symbol PCRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.